USANA Health Sciences, Inc.
USNA
$27.18
$0.080.30%
NYSE
| 12/28/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | 12/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -58.01% | 1.68% | -36.92% | -1.37% | 47.76% |
| Total Depreciation and Amortization | 5.85% | -2.51% | 12.16% | 4.37% | -5.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -80.14% | 234.82% | -146.87% | 64.10% | -6.52% |
| Change in Net Operating Assets | -164.01% | 286.70% | 59.95% | -5,172.02% | -127.15% |
| Cash from Operations | -80.41% | 269.64% | -54.82% | -32.05% | 17.04% |
| Capital Expenditure | 24.89% | 10.18% | 16.56% | 56.29% | -403.71% |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -100.00% | 50.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | 229.31% | -- | -- |
| Cash from Investing | -8,674.08% | -51.23% | 62.00% | 44.44% | -403.58% |
| Total Debt Issued | 1,150,000.00% | -101.30% | -71.32% | -32.20% | -- |
| Total Debt Repaid | 100.00% | 100.20% | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 6.33% | -154.84% | 99.75% | -9,215.67% | 98.85% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 29,497.44% | 94.24% | 88.67% | -1,915.50% | 105.65% |
| Foreign Exchange rate Adjustments | -225.00% | 633.07% | 73.17% | -193.73% | 280.06% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -662.65% | 700.34% | 290.14% | -109.14% | 240.35% |